NASDAQ:CBAY
CymaBay Therapeutics Inc
- Stock
Last Close
32.47
21/03 20:00
Market Cap
2.61B
Beta: 0.26
Volume Today
8.35M
Avg: 1.67M
PE Ratio
−23.78
PFCF: −42.19
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
asset turnover | 0.10 - | 0.07 - | ||||||||||
cash conversion cycle | -2.05K - | |||||||||||
cash per share | 2.22 - | 2.89 29.99% | 2.19 24.00% | 0.72 66.98% | 2.79 284.26% | 3.09 10.97% | 2.85 7.83% | 2.12 25.44% | 2.63 23.60% | 1.54 41.22% | 3.71 140.58% | |
company equity multiplier | 1.75 - | 2.71 54.82% | 1.53 43.37% | 4.92 220.91% | 1.23 75.04% | 1.10 10.71% | 1.10 0.75% | 1.08 2.36% | 1.52 41.19% | 3.92 157.80% | 1.49 62.09% | |
days of inventory outstanding | ||||||||||||
days of payables outstanding | 2.05K - | |||||||||||
days of sales outstanding | 182.50 - | |||||||||||
dividend yield | ||||||||||||
ebit per revenue | -2.13 - | -3.27 - | ||||||||||
ebt per ebit | 1.07 - | 1.33 24.01% | 0.60 54.89% | 1.04 73.84% | 1.29 23.97% | 1.00 22.57% | 0.95 5.00% | 0.97 1.96% | 1.03 6.02% | 1.14 10.79% | 1.04 8.97% | |
effective tax rate | -0.10 - | 0.20 313.47% | -0.77 482.11% | -0.05 93.16% | 0.17 421.45% | -0.00 102.37% | 0.01 237.76% | 0.05 718.19% | -0.03 163.05% | -0.12 323.69% | ||
enterprise value multiple | -11.59 - | -3.58 69.16% | -2.30 35.72% | -1.54 33.18% | -11.50 648.93% | -5.66 50.78% | -1.11 80.36% | -6.91 521.72% | -1.91 72.32% | -6.82 256.38% | -23.93 250.88% | |
fixed asset turnover | 144.93 - | 5.43 - | ||||||||||
free cash flow per share | -0.60 - | -1.76 192.81% | -1.23 29.92% | -1.00 19.15% | -0.56 43.55% | -0.96 70.35% | -1.47 52.72% | -0.65 55.68% | -0.98 50.63% | -0.96 1.95% | -0.69 28.37% | |
gross profit margin | 1 - | 0.98 - | ||||||||||
interest coverage | -11.43 - | -31.80 178.19% | -28.36 10.80% | -19.14 32.53% | -19.75 3.18% | -215.79 992.86% | -33.91 - | -6.25 81.58% | -5.37 14.07% | |||
inventory turnover | ||||||||||||
long term debt to capitalization | 0.19 - | 0.19 3.23% | 0.24 28.57% | 0.61 154.93% | 0.03 94.40% | 0.01 - | 0.01 5.41% | 0.28 3,063.73% | 0.71 157.46% | 0.25 64.52% | ||
net income per ebt | 1 - | 1 0% | 1 0% | 1 0% | 1 0% | 1 0% | 0.99 0.56% | 0.95 4.02% | 1.03 7.78% | 1.12 9.03% | 1 10.84% | |
net profit margin | -2.76 - | -3.39 - | ||||||||||
operating cash flow per share | -0.60 - | -1.75 191.39% | -1.23 29.58% | -1.00 19.29% | -0.56 43.53% | -0.95 68.96% | -1.46 53.70% | -0.65 55.55% | -0.98 50.52% | -0.96 2.00% | -0.68 28.68% | |
operating cycle | ||||||||||||
operating profit margin | -2.13 - | -3.27 - | ||||||||||
payables turnover | 0.18 - | |||||||||||
pretax profit margin | -2.76 - | -3.39 - | ||||||||||
price fair value | 6.81 - | 8.55 25.63% | 1.14 86.71% | 10.30 806.87% | 3.78 63.31% | 2.67 29.38% | 0.71 73.59% | 2.77 293.03% | 1.81 34.80% | 15.23 742.87% | 8.58 43.63% | |
receivables turnover | 2 - | |||||||||||
return on assets | -0.31 - | -0.85 174.80% | -0.36 57.68% | -1.38 282.19% | -0.26 80.81% | -0.39 46.96% | -0.50 27.92% | -0.32 36.34% | -0.46 44.64% | -0.84 83.16% | -0.24 71.08% | |
return on capital employed | -0.41 - | -1.41 245.57% | -0.70 50.31% | -2.55 263.15% | -0.24 90.48% | -0.42 73.49% | -0.57 36.66% | -0.37 36.46% | -0.48 30.31% | -0.74 54.71% | -0.26 65.30% | |
return on equity | -0.54 - | -2.30 325.43% | -0.55 76.03% | -6.77 1,126.50% | -0.32 95.21% | -0.43 31.23% | -0.55 28.88% | -0.34 37.84% | -0.70 104.22% | -3.29 372.19% | -0.36 89.04% | |
total debt to capitalization | 0.19 - | 0.25 27.27% | 0.25 1.31% | 0.69 177.76% | 0.07 90.31% | 0.01 - | 0.01 5.85% | 0.28 2,215.41% | 0.72 155.95% | 0.27 61.99% |
All numbers in USD (except ratios and percentages)